Pharvaris Statistics
Total Valuation
Pharvaris has a market cap or net worth of $928.56 million. The enterprise value is $638.82 million.
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025, after market close.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Pharvaris has 54.49 million shares outstanding. The number of shares has increased by 40.71% in one year.
| Current Share Class | 54.49M |
| Shares Outstanding | 54.49M |
| Shares Change (YoY) | +40.71% |
| Shares Change (QoQ) | +0.47% |
| Owned by Insiders (%) | 6.25% |
| Owned by Institutions (%) | 33.92% |
| Float | 21.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.34 |
| P/TBV Ratio | 3.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.60, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.60 |
| Quick Ratio | 12.35 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.18% and return on invested capital (ROIC) is -27.89%.
| Return on Equity (ROE) | -41.18% |
| Return on Assets (ROA) | -26.39% |
| Return on Invested Capital (ROIC) | -27.89% |
| Return on Capital Employed (ROCE) | -54.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 108 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Pharvaris has paid $1.89 million in taxes.
| Income Tax | 1.89M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.67% in the last 52 weeks. The beta is -2.85, so Pharvaris's price volatility has been lower than the market average.
| Beta (5Y) | -2.85 |
| 52-Week Price Change | -24.67% |
| 50-Day Moving Average | 15.42 |
| 200-Day Moving Average | 18.20 |
| Relative Strength Index (RSI) | 56.45 |
| Average Volume (20 Days) | 112,958 |
Short Selling Information
The latest short interest is 557,715, so 1.02% of the outstanding shares have been sold short.
| Short Interest | 557,715 |
| Short Previous Month | 590,657 |
| Short % of Shares Out | 1.02% |
| Short % of Float | 2.64% |
| Short Ratio (days to cover) | 18.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -150.83M |
| Pretax Income | -114.68M |
| Net Income | -138.96M |
| EBITDA | -150.73M |
| EBIT | -150.83M |
| Earnings Per Share (EPS) | -$2.57 |
Full Income StatementBalance Sheet
The company has $290.64 million in cash and $891,883 in debt, giving a net cash position of $289.75 million or $5.32 per share.
| Cash & Cash Equivalents | 290.64M |
| Total Debt | 891,883 |
| Net Cash | 289.75M |
| Net Cash Per Share | $5.32 |
| Equity (Book Value) | 277.21M |
| Book Value Per Share | 5.10 |
| Working Capital | 275.85M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$124.37 million and capital expenditures -$557,083, giving a free cash flow of -$135.46 million.
| Operating Cash Flow | -124.37M |
| Capital Expenditures | -557,083 |
| Free Cash Flow | -135.46M |
| FCF Per Share | -$2.49 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |